In patients with inflammatory bowel disease (IBD), increased levels of miR-16-5p and miR-21-5p (elevated in ulcerative colitis) suggested WWP1 as a target for these microRNAs, potentially contributing to IBD-associated colorectal cancer (CRC) (Zhou et al., 2021). This evidence concerns the gene WWP1 and colorectal carcinoma.